Cargando…
Implications of metabolic dysfunction associated fatty liver disease in COVID-19
Metabolic associated fatty liver disorder (MAFLD) characterizes the contributing etiologies (i.e., type 2 diabetes mellitus, metabolic syndrome, overweight) of individuals with fatty liver disease that affects 1/3(rd) of the world population. In 2020, the coronavirus disease 2019 (COVID-19) crisis w...
Autores principales: | Chakraborty, Raja, Sharma, Deepak, Kapoor, Devesh U, Dwivedi, Akanksha, Khabiya, Rakhi, Sen, Saikat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013103/ https://www.ncbi.nlm.nih.gov/pubmed/36926128 http://dx.doi.org/10.12998/wjcc.v11.i6.1275 |
Ejemplares similares
-
Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease
por: Jeeyavudeen, Mohammad Sadiq, et al.
Publicado: (2023) -
De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation
por: Han, Ma Ai Thanda, et al.
Publicado: (2021) -
Diabetes mellitus and COVID-19: Understanding the association in light of current evidence
por: Sen, Saikat, et al.
Publicado: (2021) -
Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight
por: Vasques-Monteiro, Isabela Macedo Lopes, et al.
Publicado: (2021) -
Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis
por: Pal, Shreya C, et al.
Publicado: (2023)